Display Settings:

Format

Send to:

Choose Destination

    J Diabetes Complications. 2008 Nov-Dec;22(6):395-9. Epub 2008 Apr 16.

    A possible new risk factor in diabetic patients with erectile dysfunction: homocysteinemia.

    Demir T, Cömlekci A, Demir O, Gülcü A, Caliskan S, Argun L, Secil M, Yesil S, Esen A.

    Department of Endocrinology and Metabolism, Dokuz Eylul University, School of Medicine, Izmir, Turkey. tevfikalper@yahoo.com

    INTRODUCTION AND OBJECTIVE: Increasing levels of homocysteine (Hcys) are related to decreased nitric oxide synthesis in the vascular endothelium and also to erectile dysfunction (ED). We investigated the traditional risk factors of ED and plasma levels of Hcys in diabetic patients. METHODS: Sixty-two men with type 2 diabetes and ages of between 40 and 70 years were included in the study. Detailed medical and sexual history and physical examination were performed. Erectile function was assessed with the International Index of Erectile Function. All participants were evaluated for fasting and postprandial plasma glucose, HbA1c, total cholesterol, triglyceride, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, apolipoprotein A, apolipoprotein B-100, vitamin B(12), folic acid, and plasma Hcys levels. Patients were evaluated for diabetic neuropathy. Colored penile Doppler ultrasonography was used to detect vascular abnormalities in diabetic patients with ED. RESULTS: Fasting plasma glucose, postprandial plasma glucose, and HbA1c levels were significantly higher in diabetic patients with ED (P<.05). In addition, Hcys levels were slightly high in diabetic patients with ED (P=.079). Logistic regression analysis revealed that high levels of HbA1c (P<.01) and Hcys (P<.05), and smoking status (P<.01) were the main determinants of the presence of ED in our diabetic population. CONCLUSION: We conclude that traditional risk factors, poor metabolic control, and smoking are important in ED generation in diabetic patients. In addition, Hcys, which is an important risk factor in atherogenesis, seems to be important in ED generation in diabetic patients.

    PMID: 18413215 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Patient drug information

    • Folic Acid (Folvite®)

      Folic acid is used to treat or prevent folic acid deficiency. It is a B-complex vitamin needed by the body to manufacture red blood cells. A deficiency of this vitamin causes certain types of anemia (low red blood cell c...